Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments.

ABSTRACT:

Background

Patients with follicular lymphoma (FL) often relapse or become refractory to treatment (R/R). While the R/R FL treatment landscape evolves, little is known about the priorities of patients and physicians. This discrete-choice experiment (DCE) study assessed patients' and physicians' treatment preferences, and the trade-offs they would be willing to make between efficacy, tolerability, and administration.

Methods

An online survey was conducted in US-based patients (≥18 years) with R/R FL and FL-treating physicians. The DCE was informed by a targeted literature review, clinical data, expert oncologist input, and pilot interviews. Participants completed eight experimental choice tasks where they chose between two hypothetical treatment profiles defined by six attribu

SUBMITTER: Thomas C 

PROVIDER: S-EPMC11470200 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature